Efficacy and safety of deep hyperthermia combined with tislelizumab and chemotherapy in the treatment of advanced squamous non-small-cell lung cancer: a single-center retrospective study - Poll - MDSpire

Efficacy and safety of deep hyperthermia combined with tislelizumab and chemotherapy in the treatment of advanced squamous non-small-cell lung cancer: a single-center retrospective study

  • By

  • LiYing Guo

  • Jinshuo Wang

  • Dongjie Du

  • April 30, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of deep hyperthermia combined with tislelizumab and chemotherapy in the treatment of advanced squamous non-small-cell lung cancer: a single-center retrospective study

  • by LiYing Guo, Jinshuo Wang, Dongjie Du

  • April 30, 2026

Related Content

County-Level Structural Racism Indices and Racial Disparities in Lung Cancer Care

Organ-specific pre-metastatic and metastatic niches in colorectal cancer: “discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis”

Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients